Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00282
|
|||||
| Drug Name |
L-histidine
|
|||||
| Synonyms |
Histidine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | HARS Syndrome [ICD11: N.A.] | Phase 2/3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H9N3O2
|
|||||
| Canonical SMILES |
C1=C(NC=N1)CC(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1
|
|||||
| InChIKey |
HNDVDQJCIGZPNO-YFKPBYRVSA-N
|
|||||
| CAS Number |
CAS 71-00-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 155.15 | Topological Polar Surface Area | 92 | ||
| Heavy Atom Count | 11 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-3.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10533543
, 11108714
, 11111281
, 14716013
, 15170951
, 15321675
, 15321676
, 24877543
, 24895605
, 24895728
, 24895816
, 26702395
, 26706813
, 26706844
, 26707943
, 26713139
, 29225269
, 3136567
, 3435
, 46392155
, 46392410
, 46507001
, 47960030
, 48416085
, 49747685
, 49856391
, 50111080
, 53787754
, 56269952
, 57323310
, 57651378
, 57654248
, 587554
, 609693
, 75529724
, 7847100
, 81044555
, 81067341
, 8145060
, 8153954
, 824156
, 83549210
, 85164887
, 87235989
, 87570592
, 88835368
, 90340851
, 92297850
, 99224367
, 99452993
|
|||||
| ChEBI ID |
ChEBI:15971
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | LAT1 | Transporter Info | L-type amino acid transporter 1 | Substrate | [2] | |
| PHT2 | Transporter Info | Peptide/histidine transporter 2 | Substrate | [3] | ||
| PTR4 | Transporter Info | Peptide transporter 4 | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | PTR4 | Transporter Info | Km = 16.3 microM | Xenopus laevis oocytes-PTR4 | [4] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT02924935) Histidine Therapy: A Project to Treat HARS Deficiency | |||||
| 2 | The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health. Front Chem. 2018 Jun 22;6:243. | |||||
| 3 | Di- and tripeptide transport in vertebrates: the contribution of teleost fish models. J Comp Physiol B. 2017 Apr;187(3):395-462. | |||||
| 4 | Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells. Mol Pharm. 2018 Feb 5;15(2):385-393. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.